Catalyst Wire Dossier Catalyst Wire Dossier

DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM

Drospirenone; Ethinyl estradiol; Levomefolate calcium · Lupin Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM, covering 2018-06-13 to 2023-10-19. Get the full timeline:

Most recent: FDA Approved: DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

See pricing